CTIDR Logo

Professor Paul Anantharajah Tambyah

Member

Prof. Tambyah

Role

Member

Institution

Yong Loo Lin School of Medicine, National University of Singapore

About Professor Paul Anantharajah Tambyah


Professor Paul Anantharajah Tambyah is Professor of Medicine at the Yong Loo Lin School of Medicine, National University of Singapore, Research Director in the Division of Infectious Diseases at the National University Health System, and Senior Consultant in Infectious Diseases at the National University Hospital. He also serves as a visiting consultant to Singapore’s National Centre for Infectious Diseases and Armed Forces. A distinguished clinician-scientist and institution builder, he was the founding head of the NUS Division of Infectious Diseases, has led major regional and international professional organisations, and served as President of the International Society for Infectious Diseases (ISID) from 2022 to 2025—the first Asian to hold that position. He has also led the Asia Pacific Society of Clinical Microbiology and Infection and the Society of Infectious Diseases Singapore. His research encompasses emerging infectious diseases, outbreak preparedness, influenza, dengue, COVID-19, antimicrobial resistance, healthcare-associated infections—particularly catheter-associated urinary tract infections—infection prevention, rapid diagnostics, clinical research and the ethics of infectious-disease control and global health. He has received numerous honours, including Singapore’s Distinguished Senior Clinician Award, the Red Ribbon Award for contributions to HIV-related causes, and military service medals for his work during the Gulf War. Professor Tambyah brings to the CTIDR an exceptional combination of clinical infectious-disease expertise, research governance, hospital and outbreak-response experience, international scientific leadership, mentorship, ethical and policy insight, and a powerful global network; critically, he could help the Centre translate its vector, pathogen and surveillance discoveries into clinically meaningful studies, strengthen infection-control and research-quality systems, build productive links with Asian and international institutions, and position CTIDR as a trusted African partner in global emerging-infection preparedness.